Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Tables)

v3.22.2.2
Stockholders’ Equity (Tables)
 9 Months Ended
Sep. 30, 2022
Stockholders' Equity Note [Abstract]  
Schedule of warrant and stock option grants with time-based vesting
    Warrant Grants     Stock Option Grants     Restricted Stock Units  
    Number of
shares
subject to
warrants		     Weighted-
average
exercise
price per
share		     Number of
shares
subject to
options		     Weighted-
average
exercise
price per
share		     Number of
shares
subject to
restricted
stock units		  
Balance at December 31, 2021     1,043,525     $ 2.57       118,388     $ 3.25       2,160,757  
Granted     524,195       0.65      
-
      
-
       465,314  
Exercised    
-
      
-
      
-
      
-
       (213,312 )
Cancelled/Expired    
-
      
-
      
-
      
-
      
-
  
Balance at September 30, 2022     1,567,720     $ 1.49       118,388     $ 3.25       2,412,759  
Exercisable at September 30, 2022     1,567,720     $ 1.49       118,388     $ 3.25       2,108,884  

 
Schedule of company’s outstanding warrants and options
Warrants Outstanding   Warrants Exercisable  
Exercise Price
Range		   Number Outstanding     Weighted
Average
Remaining
Contractual
 Life 
(in years)		     Weighted
Average
Exercise
 Price		     Number
Exercisable		     Weighted
Average
Exercise
 Price		     Intrinsic
Value		  
$0.65 - $20.90     1,567,720       2.81     $ 1.35       1,567,720     $ 1.35       79,478  

 

Options Outstanding   Options Exercisable  
Exercise Price
Range		   Number Outstanding     Weighted
Average
Remaining
Contractual
Life
(in years)		     Weighted
Average
Exercise 
Price		     Number
Exercisable		     Weighted
Average
Exercise
Price		     Intrinsic
Value		  
$2.64 - $28.50     118,388       1.94     $ 3.25       118,388     $ 3.25      
-
  

 
Schedule of stock-based compensation expense
    For the three months ended
     For the nine months ended
  
    September 30,     September 30,  
    2022     2021     2022     2021  
Stock-based compensation expense   $ 261,370     $ 699,084     $ 906,919     $ 1,929,446  

 
Schedule of stock-based compensation expense categorized by the equity components
    For the three months ended
     For the nine months ended
  
    September 30,     September 30,  
    2022     2021     2022     2021  
Common stock   $ 261,370     $ 699,084     $ 906,919     $ 1,929,446  
Total   $ 261,370     $ 699,084     $ 906,919     $ 1,929,446